Katherine Cooper

STATIN THERAPY AND IMPROVED WAITLIST OUTCOMES IN LIVER TANS PANT CANDIDATES WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) CIRRHOSIS
Date
May 18, 2024
Introduction: There is increasing data to support the beneficial effects of statin medications on liver disease including reducing the development of hepatic fibrosis in metabolic associated steatotic liver disease (MASLD)/metabolic associated steatohepatitis (MASH) and reducing mortality in patien…
Presenter
Katherine Cooper
Speakers
Ami Patel
Alessandro Colletta
Deepika Devuni
Clinical Advances in Steatotis Liver Disease and MASH
Date
May 18, 2024
SOCIETY: AGA Newer and novel tools in understanding and management of patients with MASLD
Moderators
Gyongyi Szabo
Beth Israel Deaconess Medical Center
Richard K. Sterling
Virginia Commonwealth Univ.
Speakers
Aaron Yeoh
Stanford University Hospital
Stefani Tica
Lin Cai
Rayna Patel
Katherine Cooper
Robert Wong
SYSTEMIC HORMONAL CONTRACEPTION IS PROTECTIVE AGAINST CHOLANGIOCARCINOMA IN REPRODUCTIVE-AGED WOMEN WITH PRIMARY SCLEROSING CHOLANGITIS.
Date
May 4, 2025
Speaker
Katherine Cooper